Investing
US FTC seeks additional info on Pfizer’s proposed takeover of Seagen
© Reuters. FILE PHOTO: The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo/File Photo
2/2
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related to Pfizer (NYSE:)’s proposed acquisition of Seagen Inc, Seagen said on Friday.
The antitrust agency sent the requests separately to both the companies, a regulatory filing said.
Pfizer struck a $43 billion deal in March to acquire Seagen and its targeted cancer therapies, to counter the fall in COVID-related sales and generic competition for some top-selling drugs.
The recent scrutiny by the antitrust agency to block Amgen (NASDAQ:)’s $27.8 billion deal to buy Horizon Therapeutics (NASDAQ:) has made investors jittery around the Pfizer-Seagen deal as well.
Seagan continues to expect its merger with Pfizer will be completed in late 2023 or early 2024, it said in the filing.
Read the full article here
-
Investing6 days ago
Moldova breakaway region to face new power cuts on Saturday, officials say By Reuters
-
Investing6 days ago
Reebok Co-Founder Backs Syntilay’s New AI, 3D-Printed Shoe
-
Side Hustles6 days ago
How to Survive High-Demand Seasons Without Losing Customers
-
Side Hustles4 days ago
5 Things That Could Significantly Impact Your Company in 2025
-
Investing4 days ago
NFI Group surge after board reshaped with new appointments, chairperson By Investing.com
-
Side Hustles6 days ago
Shake It Up — Dunkin’ Debuts Star-Backed Winter Menu
-
Side Hustles5 days ago
How Failing 22 Times Paved the Way to My Success
-
Make Money6 days ago
9 Easy Steps to Begin Your Gold Investment Journey